DHTKD1 and lymphoma: For instance, several types of tumors, including lymphomas and malignant brain tumors, overexpress the DHTKD1-encoded OADH (Kiełbus et al., 2015; Papatheodorou et al., 2018), and inhibition of OADH in such tumors by AP may be a plausible therapeutic strategy.